Skip to content

The Multidimensional Code of Cerebral Small Vessel Disease: A Longitudinal Study on the Association Between Inflammation, Blood Pressure Variability, and Cognitive and Imaging Burden

A Prospective Study on Multidimensional Biomarkers of Cerebral Small Vessel Disease: Longitudinal Association Analysis of Inflammation, Blood Pressure Variability, Cognitive Function, and Imaging Total Burden

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118337
Enrollment
Unknown
Registered
2026-02-04
Start date
2025-02-01
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with cerebral small vessel disease, and MRI imaging shows typical manifestations of cerebral small vessel disease, such as white matter hyperintensities, lacunar infarcts, cerebral microbleeds, and enlarged perivascular spaces.

Interventions

Case group:None

Sponsors

Shanxi Cardiovascular Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged 18 years or older. 2.Clinically diagnosed with cerebral small vessel disease, and MRI imaging shows typical manifestations of cerebral small vessel disease, such as white matter hyperintensities, lacunar infarcts, cerebral microbleeds, and enlarged perivascular spaces. 3.Willing to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Within 3 months of the onset of an acute cerebrovascular event. 2. Patients with severe stroke and previous brain disease, neurological infections, head trauma, demyelinating diseases, neurodegenerative diseases and brain tumours, such as Alzheimer's disease and Parkinson's disease. 3. with severe systemic diseases such as heart failure, liver and renal insufficiency. 4. have used medications within the last 3 months that may affect inflammatory factor levels or cognitive function. 5. the presence of mental illness or cognitive dysfunction that would interfere with study co-operation. 6. subjects with life expectancy = 5 years due to advanced cancer and other diseases. 7. contraindications to MRI examination.

Design outcomes

Primary

MeasureTime frame
Cognitive assessment;Total Burden Score of Imaging for Cerebral Small Vessel Disease;

Secondary

MeasureTime frame
Ambulatory Blood Pressure Monitoring;Levels of inflammatory markers;

Countries

China

Contacts

Public ContactWeirongLee

Shanxi Cardiovascular Hospital

weironglee@163.com+86 351 5275542

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026